臓器移植免疫抑制薬市場：薬効クラス、移植タイプ、流通チャネル別-2023-2030年の世界予測

臓器移植免疫抑制薬の世界市場は、2023年に42億4,374万米ドル、CAGR7.02％で大きく成長し、2030年には68億5,546万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の臓器移植免疫抑制薬市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.臓器移植免疫抑制薬の世界市場規模および予測は？

2.予測期間中、世界の臓器移植免疫抑制薬市場を形成するCOVID-19の阻害要因と影響は？

3.臓器移植免疫抑制薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.臓器移植免疫抑制薬の世界市場における競争戦略は？

5.臓器移植免疫抑制薬の世界市場における技術動向と規制の枠組みは？

6.臓器移植免疫抑制薬の世界市場における主要ベンダーの市場シェアは？

7.臓器移植免疫抑制薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臓器移植の需要の増加
    • 規制当局による新製品の承認の増加
    • 臓器提供を促進する政府とNGOの取り組み
  • 抑制要因
    • 免疫抑制剤の調査に重点を置く医療専門家の不足
  • 機会
    • 臓器移植医薬品開発における広範な技術開発
    • 臓器移植免疫抑制薬に対して有利な払い戻しが可能です
  • 課題
    • 生存可能な臓器の不足
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 臓器移植免疫抑制薬市場薬物クラス別

• 抗体
• 抗増殖剤
• カルシニューリン阻害剤
• mTOR阻害剤
• ステロイド

第7章 臓器移植免疫抑制薬市場移植タイプ別

• 心臓
• 腎臓
• 肝臓
• 肺
• 膵臓

第8章 臓器移植免疫抑制薬市場：流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第9章 南北アメリカの臓器移植免疫抑制薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の臓器移植免疫抑制薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの臓器移植免疫抑制薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2022 VS 2030
• FIGURE 3. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
• FIGURE 5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2022 VS 2030 (%)
• FIGURE 6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET DYNAMICS
• FIGURE 9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 5. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ANTIPROLIFERATIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY MTOR INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STEROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 11. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 17. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY TRANSPLANT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 148. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 149. ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET LICENSE & PRICING

The Global Organ Transplant Immunosuppressant Drugs Market is forecasted to grow significantly, with a projected USD 4,243.74 million in 2023 at a CAGR of 7.02% and expected to reach a staggering USD 6,855.46 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Organ Transplant Immunosuppressant Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Organ Transplant Immunosuppressant Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Class, market is studied across Antibodies, Antiproliferative Agents, Calcineurin Inhibitors, mTOR Inhibitor, and Steroids. The Antibodies is projected to witness significant market share during forecast period.

Based on Transplant Type, market is studied across Heart, Kidney, Liver, Lung, and Pancreas. The Pancreas is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Organ Transplant Immunosuppressant Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Organ Transplant Immunosuppressant Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Organ Transplant Immunosuppressant Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Organ Transplant Immunosuppressant Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Organ Transplant Immunosuppressant Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Organ Transplant Immunosuppressant Drugs Market?

6. What is the market share of the leading vendors in the Global Organ Transplant Immunosuppressant Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Organ Transplant Immunosuppressant Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Organ Transplant Immunosuppressant Drugs Market, by Drug Class, 2022 vs 2030
• 4.3. Organ Transplant Immunosuppressant Drugs Market, by Transplant Type, 2022 vs 2030
• 4.4. Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel, 2022 vs 2030
• 4.5. Organ Transplant Immunosuppressant Drugs Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand for organ transplantation
    • 5.1.1.2. Growing approval for new products by the regulatory bodies
    • 5.1.1.3. Government & NGO initiatives promoting organ donation
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of medical professionals focused on immunosuppressants research
  • 5.1.3. Opportunities
    • 5.1.3.1. Extensive technological developments in organ transplants drug development
    • 5.1.3.2. Favorable reimbursement available for organ transplant immunosuppressant drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of availability of viable organs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Organ Transplant Immunosuppressant Drugs Market, by Drug Class

• 6.1. Introduction
• 6.2. Antibodies
• 6.3. Antiproliferative Agents
• 6.4. Calcineurin Inhibitors
• 6.5. mTOR Inhibitor
• 6.6. Steroids

7. Organ Transplant Immunosuppressant Drugs Market, by Transplant Type

• 7.1. Introduction
• 7.2. Heart
• 7.3. Kidney
• 7.4. Liver
• 7.5. Lung
• 7.6. Pancreas

8. Organ Transplant Immunosuppressant Drugs Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Americas Organ Transplant Immunosuppressant Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Organ Transplant Immunosuppressant Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Organ Transplant Immunosuppressant Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing